Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Jingky Lozano-Kuehne.
Newcastle Authors
Title
Year
Full text
Dr Jingky Lozano-Kuehne
A subset of non-small cell lung cancer patients treated with Pemetrexed show
18
F-Fluorothymidine “Flare” on Positron Emission Tomography
2023
Dr Jingky Lozano-Kuehne
Dr Nicola Cresti
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer (Nature Communications, (2022), 13, 1, (3246), 10.1038/s41467-022-30666-0)
2023
Dr Jingky Lozano-Kuehne
Spatial and temporal intra-tumoural heterogeneity in advanced High-Grade Serous Ovarian Cancer: implications for surgical and clinical outcomes
2023
Dr Jingky Lozano-Kuehne
[18F]Fluorothymidine(FLT)-PET imaging of thymidine kinase 1 pharmacodynamics in non-small cell lung cancer treated with pemetrexed
2022
Dr Jingky Lozano-Kuehne
Dr Nicola Cresti
Professor Ruth Plummer
Results of the Phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
2022
Dr Jingky Lozano-Kuehne
The HERPET study: Imaging HER2 expression in breast cancer with the novel PET tracer [
18
F]GE-226, a first-in-patient study
2022
Dr Jingky Lozano-Kuehne
Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: an international, multicentre, retrospective study
2021
Dr Jingky Lozano-Kuehne
[
18
F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer
2020
Dr Jingky Lozano-Kuehne
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
2020
Dr Jingky Lozano-Kuehne
[
18
F] Fluciclatide PET as a biomarker of clinical response to combination therapy of pazopanib and paclitaxel in patients with platinum-resistant or platinum-refractory advanced ovarian cancer: Results of a phase Ib study
2019
Dr Jingky Lozano-Kuehne
[
18
F]Fluciclatide PET As A Biomarker Of Response To Combination Therapy Of Pazopanib And Paclitaxel In Platinum-resistant/refractory Ovarian Cancer
2019
Dr Jingky Lozano-Kuehne
Altered cytochrome 2E1 and 3A P450‐dependent drug metabolism in advanced ovarian cancer correlates to tumour‐associated inflammation
2019
Dr Jingky Lozano-Kuehne
Cost-effectiveness of simvastatin plus ezetimibe for cardiovascular prevention in chronic kidney disease: results of the SHARP trial
2016
Dr Jingky Lozano-Kuehne
An assessment of chronotype and social jet lag among Filipinos
2015
Dr Jingky Lozano-Kuehne
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
2015
Dr Jingky Lozano-Kuehne
Genetic Variation I148M in Patatin-Like Phospholipase 3 Gene and Risk of Non-Alcoholic Fatty Liver Disease Among Filipinos
2014
Dr Jingky Lozano-Kuehne
Cancer Resources
2013
Dr Jingky Lozano-Kuehne
Disease Databases
2013
Dr Jingky Lozano-Kuehne
SNPedia
2013
Dr Jingky Lozano-Kuehne
Allelic and genotype frequencies of catechol-Omethyltransferase (Val158Met) and CYP2D6*10 (Pro34Ser) single nucleotide polymorphisms in the Philippines
2012
Dr Jingky Lozano-Kuehne
Association of glutathione S-transferase T1 and M1 genotypes with chronic liver diseases among Filipinos
2012
Dr Jingky Lozano-Kuehne
Shift work research in the Philippines: current state and future directions
2012
Dr Jingky Lozano-Kuehne
A generalized method for analyzing genetic main effects and epistasis among candidate genes using parent-offspring trios
2010
Dr Jingky Lozano-Kuehne
Foundations of Statistical Analysis for the Health Science
2010
Dr Jingky Lozano-Kuehne
Generalized Method in Candidate Gene Analysis for Nonnormally Distributed Quantitative Traits using Family Trios
2010
Dr Jingky Lozano-Kuehne
Generalized Quantitative Transmission Disequilibrium Test for Analyzing Genetic Main Effects and Epistasis
2010
Dr Jingky Lozano-Kuehne
The endogenous danger signals HSP70 and MICA cooperate in the activation of cytotoxic effector functions of NK cells
2010
Dr Jingky Lozano-Kuehne
Tests for candidate gene interaction for longitudinal quantitative traits measured in a large cohort
2009
Dr Jingky Lozano-Kuehne
Issues in association mapping with high-density SNP data and diverse family structures
2007
Dr Jingky Lozano-Kuehne
The heat shock protein HSP70 promotes mouse NK cell activity against tumors which express inducible NKG2D ligands
2007
Dr Jingky Lozano-Kuehne
Chest radiograph aortic arch calcification is a surrogate marker of coronary artery disease
2004